Jardiance and Exercise: What Women Need to Know Before, During, and After Your Workout

How Jardiance Actually Works During Exercise

Empagliflozin blocks the sodium-glucose cotransporter 2 (SGLT2) in your kidney tubules, which means roughly 60 to 90 grams of glucose per day spill into your urine rather than returning to your bloodstream. During exercise, your muscles demand glucose fast. That extra urinary glucose loss is already happening before you lace up your shoes, so your glycogen stores and circulating blood glucose may be lower than you expect going into a workout.

This is not a reason to avoid exercise. It is a reason to understand your fuel state before you begin.

The glycogen and fat-burning shift

A secondary effect worth knowing: SGLT2 inhibition subtly promotes fat oxidation at rest and during moderate-intensity exercise. A 2019 study in Diabetes Care found that empagliflozin-treated adults showed a measurable increase in ketone body production and fat utilization compared to placebo. For women managing weight alongside type 2 diabetes or heart failure, this metabolic shift may amplify some of the body-composition benefits of regular aerobic exercise, though the degree of benefit varies considerably by individual.

Intensity matters

Low-to-moderate intensity exercise (brisk walking, cycling at a conversational pace, yoga, swimming) carries the least risk of glucose instability on Jardiance. High-intensity interval training (HIIT) and prolonged endurance exercise above 60 minutes both cause a larger acute glucose draw and may exaggerate the gap between what your muscles need and what is available in your blood.

Hypoglycemia Risk on Jardiance: Specific Numbers for Women

Jardiance as monotherapy carries a very low independent risk of hypoglycemia because it does not stimulate insulin secretion. The EMPA-REG OUTCOME trial, which enrolled 7,020 adults with type 2 diabetes and cardiovascular disease, reported confirmed hypoglycemia in roughly 2.9% of participants on empagliflozin versus 2.1% on placebo, and most events occurred in participants who were also taking a sulfonylurea or insulin.

If you take Jardiance alongside insulin glargine, insulin lispro, or a sulfonylurea such as glipizide or glimepiride, your exercise hypoglycemia risk rises substantially. Talk to your clinician about a pre-exercise insulin dose reduction before starting a new workout program.

Signs of low blood sugar to watch for during a workout

• Shakiness, trembling, or sudden weakness mid-set
• Sweating disproportionate to your effort level (note: this overlaps with normal exercise sweat and hot flashes in perimenopause, which makes it harder to detect)
• Confusion, difficulty concentrating, or tunnel vision
• Heart pounding or irregular rhythm sensation
• Blood glucose reading below 70 mg/dL on a continuous glucose monitor (CGM) or fingerstick

If you use a CGM

Wearing a CGM is one of the most practical tools available for women on Jardiance who exercise regularly. Real-time glucose data lets you see whether a 45-minute run drops you to 80 mg/dL or holds steady at 110 mg/dL, eliminating guesswork. A 2021 Diabetes Care consensus report on glucose targets during exercise recommends starting aerobic exercise with a glucose of 90 to 180 mg/dL and consuming 15 to 30 grams of fast-acting carbohydrate if you drop below 90 mg/dL during activity.

Dehydration: The Risk Most Women on Jardiance Underestimate

Empagliflozin is an osmotic diuretic. It pulls water out of your body along with the glucose it spills into urine. You lose more fluid at rest on this drug than you would without it. Add an hour of exercise in a warm gym, and the cumulative fluid loss becomes clinically significant.

How much extra fluid do you need?

There is no single randomized trial that has quantified the precise additional fluid requirement for women exercising on SGLT2 inhibitors. What exists is extrapolation from the drug's known diuretic mechanism combined with standard sports nutrition guidance. The American College of Sports Medicine position stand on hydration recommends 400 to 600 mL of fluid in the two hours before exercise for the general population. For women on Jardiance, adding an extra 240 to 480 mL on top of that baseline is a reasonable starting point, adjusted for body size, exercise intensity, ambient temperature, and sweat rate.

Practical markers that you are adequately hydrated:

• Urine is pale yellow (not colorless, not dark amber)
• No significant thirst at the start of your workout
• Body weight within 1% of your pre-exercise weight after finishing

Electrolytes matter too

Because glucose-driven diuresis also carries sodium, potassium, and magnesium out of the body, plain water alone may not fully replace what you lose during longer sessions. For workouts beyond 60 minutes, an electrolyte-containing drink (without excessive added sugar) is more effective than water alone. Women with heart failure on Jardiance should check fluid and sodium targets with their cardiologist before changing their hydration strategy, since volume management in heart failure is individualized.

Yeast Infections, Sweat, and Vaginal Health: A Section Most Articles Skip

Glucose in the urine changes the local environment around your vulva and vaginal opening. Yeast (primarily Candida albicans) thrives in warm, moist, glucose-rich environments, which is exactly what you create during a workout in synthetic fabric workout gear. Genital mycotic infections were reported in 10.0% of women taking empagliflozin 10 mg compared to 2.6% on placebo in pooled clinical trial data.

This is the most common side effect that affects women differently than men on this drug. Men develop genital yeast infections too, but at a lower rate (4.8% vs 1.0% for placebo in the same dataset), and their anatomy means moisture and friction are less concentrated.

Practical steps to reduce yeast infection risk

1. Change out of sweaty workout clothes immediately after exercise. Do not sit in damp activewear.
2. Choose moisture-wicking, breathable fabrics (cotton-lined gusset or 100% cotton underwear post-workout).
3. Shower promptly after exercise and dry the genital area thoroughly.
4. If you have had more than two yeast infections since starting Jardiance, speak with your clinician about prophylactic antifungal options and whether the 10 mg vs 25 mg dose difference changes your personal risk.
5. Urinary tract infections are also modestly elevated on SGLT2 inhibitors. If you develop burning with urination, increased frequency, or pelvic pressure, seek evaluation promptly.

Life-Stage Differences: How Exercise on Jardiance Changes Across a Woman's Life

Reproductive years (ages roughly 18 to 40)

Women of childbearing age using Jardiance for type 2 diabetes, PCOS-related insulin resistance, or early heart disease need reliable contraception. Empagliflozin is contraindicated in pregnancy (see the dedicated section below). Exercise during reproductive years on Jardiance is generally well tolerated, but women with PCOS should know that the combination of regular aerobic exercise and SGLT2 inhibition may produce additive improvements in insulin sensitivity. A 2023 meta-analysis in Fertility and Sterility found that SGLT2 inhibitors improved menstrual regularity and androgen markers in PCOS, though the studies were small and predominantly observational.

Trying to conceive

Empagliflozin should be stopped before attempting conception or as soon as pregnancy is confirmed (see below). If you are actively trying to conceive, do not restart Jardiance without confirmed negative pregnancy status. Exercise remains beneficial during the preconception period and does not interact with the drug in this specific context beyond the general guidance above.

Perimenopause (typically ages 45 to 55)

This is the life stage where Jardiance's exercise effects become most complex. Perimenopause brings:

• Estrogen decline, which reduces insulin sensitivity independently
• Vasomotor symptoms (hot flashes, night sweats) that already impair thermoregulation
• Accelerated bone turnover

Jardiance's osmotic diuresis compounds perimenopausal hot-flash sweating, raising dehydration risk well above the general population. A woman having eight hot flashes per day is already losing meaningful fluid before her first gym visit. Hydration planning on Jardiance in perimenopause needs to account for both.

On bone: SGLT2 inhibitors have been associated with modestly increased fracture risk in some populations, though the EMPA-REG OUTCOME trial did not find a statistically significant fracture signal with empagliflozin specifically. The FDA label for empagliflozin does not include a boxed warning for fracture. Still, perimenopausal and postmenopausal women should prioritize weight-bearing and resistance exercise, which builds bone density, while on this drug.

Postmenopause

Postmenopausal women using Jardiance for cardiovascular protection (the EMPEROR-Reduced and EMPEROR-Preserved trials enrolled significant numbers of older women with heart failure) should pay particular attention to orthostatic hypotension risk after exercise. Jardiance lowers blood pressure modestly through the diuretic mechanism. Standing quickly after floor exercises or getting out of a pool can trigger dizziness. Rise slowly, pause at the seated position, and check blood pressure at rest before resuming activity if you have felt lightheaded.

Pregnancy, Lactation, and Contraception: Required Reading

Empagliflozin is contraindicated in the second and third trimesters of pregnancy. Animal data show fetal kidney toxicity when SGLT2 inhibitors are given during the period of kidney development, which corresponds to the second and third trimesters in humans. The FDA label explicitly states that empagliflozin should be discontinued when pregnancy is detected, and the drug is listed as FDA Pregnancy Category Not Assigned under the current labeling system with a specific warning against second- and third-trimester use.

First trimester human data is limited. The current guidance from ACOG does not recommend SGLT2 inhibitors for diabetes management during pregnancy, whether gestational or pre-existing. Insulin remains the standard of care for diabetes in pregnancy.

Lactation: Empagliflozin has been detected in the milk of lactating rats. Human breast milk transfer data is not available. Because the drug causes diuresis, there is a theoretical concern about reduced milk supply in addition to unknown infant exposure. The manufacturer recommends against breastfeeding while taking empagliflozin. LactMed (NIH) classifies the risk as unknown and recommends avoiding use during lactation.

Contraception requirement: Any woman of reproductive potential taking Jardiance should use reliable contraception. This is not optional. Discuss your specific contraceptive method with your clinician, particularly if you are using hormonal contraception that may itself affect insulin sensitivity or cardiovascular risk.

Who Exercise on Jardiance Is Right For, and Who Needs Extra Caution

Good candidates for starting or continuing exercise on Jardiance

• Women with type 2 diabetes, well-controlled, on Jardiance as monotherapy or with metformin
• Women with stable heart failure (HFrEF or HFpEF) cleared for activity by their cardiologist
• Women with CKD stages 2 to 3 on Jardiance for kidney protection, cleared for exercise
• Women with PCOS using Jardiance off-label for metabolic management
• Postmenopausal women using Jardiance for cardiovascular risk reduction

Situations requiring additional caution or clinician clearance before exercising

• Concurrent insulin or sulfonylurea use (hypoglycemia risk)
• Recurrent genital yeast or urinary tract infections not yet controlled
• Active volume depletion, significant nausea/vomiting, or fever (Jardiance should be held during illness)
• Euglycemic diabetic ketoacidosis (eDKA) history. Low-carbohydrate diets combined with prolonged intense exercise can precipitate eDKA on SGLT2 inhibitors even at normal blood glucose. If you follow a ketogenic or very-low-carbohydrate diet and train at high intensity, this is a real and underrecognized risk.
• eGFR below 30 mL/min/1.73 m² (empagliflozin's glucose-lowering effect is reduced at low eGFR and the drug is generally not started in this range)

Daily Life on Jardiance: Practical Adjustments Beyond the Gym

Living with Jardiance means making a few daily-life shifts that accumulate into meaningful habit changes.

Morning timing and your workout schedule

The standard clinical instruction is to take Jardiance in the morning with or without food. If you work out in the morning, this creates a question about sequencing. Taking your dose after your workout rather than before is not supported by formal trial data, but the pharmacokinetics of empagliflozin show peak plasma concentration at roughly 1.5 hours after ingestion with a half-life of 12 to 13 hours. FDA pharmacokinetic data confirms that once-daily dosing produces stable 24-hour coverage, meaning the timing difference of 60 to 90 minutes for an early-morning workout is unlikely to substantially change your risk profile on any given day. Do not rearrange your dosing schedule without discussing it with your prescriber.

Sick day rules and exercise

Jardiance should be held during intercurrent illness, prolonged fasting, or surgical procedures. The same principle applies to extreme-condition exercise: a marathon or a multiday backcountry hike is not the week to push through if you are already dehydrated or under-fueled. The risk of eDKA rises when carbohydrate intake drops sharply alongside intense physical stress. The American Diabetes Association's 2024 Standards of Care recommend holding SGLT2 inhibitors 3 to 4 days before any major surgical procedure, a guideline that can be applied broadly to major physical events.

Alcohol and exercise recovery

Alcohol is both a diuretic and a hepatic glucose suppressor. Drinking after exercise while on Jardiance stacks three separate hypoglycemic and dehydrating effects: the glucose loss from the drug, the glucose drop from exercise, and alcohol's suppression of hepatic glucose output. A single standard drink is unlikely to cause a serious event in most women not on insulin, but post-workout drinking warrants extra attention to food intake and hydration.

Monitoring weight changes

Jardiance produces both fat loss and volume loss (from diuresis). Early on, the scale may drop 1 to 2 kg in the first two to four weeks largely because of fluid, not fat. Over 12 to 52 weeks, the EMPA-REG OUTCOME trial showed a mean body weight reduction of approximately 2.0 to 3.0 kg sustained at one year versus placebo. Regular exercise amplifies the fat-loss component while preserving lean mass, which is why the combination is clinically meaningful. Track your weight at the same time of day (ideally morning, post-void) to reduce day-to-day fluid noise.

What the Evidence Gap Looks Like for Women

Women have historically been underenrolled in cardiovascular and metabolic trials. In EMPA-REG OUTCOME, women made up approximately 28.5% of participants. The EMPEROR-Preserved trial had better representation, with women comprising roughly 45% of the cohort, but exercise-specific subgroup analyses by sex are sparse in published data.

This means most of what is described above for exercise is extrapolated from a trial population that was predominantly male, White, and older. Real-world exercise physiology data specific to women on empagliflozin, particularly around hormonal cycle effects on glucose variability and exercise performance, is essentially absent from the published literature. This is an honest gap. If you notice patterns in your own exercise tolerance, recovery, or glucose readings that do not match what your clinician expects, your lived data is worth documenting and discussing. A CGM used for two to four weeks can generate individualized patterns that no trial has yet captured at scale.